These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23941888)

  • 1. Voltage gated sodium and calcium channel blockers for the treatment of chronic inflammatory pain.
    Rahman W; Dickenson AH
    Neurosci Lett; 2013 Dec; 557 Pt A():19-26. PubMed ID: 23941888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Update On Proficiency of Voltage-gated Ion Channel Blockers in the Treatment of Inflammation-associated Diseases.
    Kelkar S; Nailwal N; Bhatia NY; Doshi G; Sathaye S; Godad AP
    Curr Drug Targets; 2022; 23(14):1290-1303. PubMed ID: 35996239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central mechanisms of menthol-induced analgesia.
    Pan R; Tian Y; Gao R; Li H; Zhao X; Barrett JE; Hu H
    J Pharmacol Exp Ther; 2012 Dec; 343(3):661-72. PubMed ID: 22951274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecules targeting sodium and calcium channels for neuropathic pain.
    Bear B; Asgian J; Termin A; Zimmermann N
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):543-61. PubMed ID: 19562650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic Effects of Topical Amitriptyline in Patients With Chemotherapy-Induced Peripheral Neuropathy: Mechanistic Insights From Studies in Mice.
    Genevois AL; Ruel J; Penalba V; Hatton S; Petitfils C; Ducrocq M; Principe P; Dietrich G; Greco C; Delmas P
    J Pain; 2021 Apr; 22(4):440-453. PubMed ID: 33227509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathic pain: preclinical and early clinical progress with voltage-gated sodium channel blockers.
    Kushnarev M; Pirvulescu IP; Candido KD; Knezevic NN
    Expert Opin Investig Drugs; 2020 Mar; 29(3):259-271. PubMed ID: 32070160
    [No Abstract]   [Full Text] [Related]  

  • 7. The Natural Flavonoid Naringenin Elicits Analgesia through Inhibition of NaV1.8 Voltage-Gated Sodium Channels.
    Zhou Y; Cai S; Moutal A; Yu J; Gómez K; Madura CL; Shan Z; Pham NYN; Serafini MJ; Dorame A; Scott DD; François-Moutal L; Perez-Miller S; Patek M; Khanna M; Khanna R
    ACS Chem Neurosci; 2019 Dec; 10(12):4834-4846. PubMed ID: 31697467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Targets for the Management of Osteoarthritis Pain.
    Malfait AM; Miller RJ
    Curr Osteoporos Rep; 2016 Dec; 14(6):260-268. PubMed ID: 27730452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfen is a broad-spectrum calcium channel inhibitor with analgesic properties in mouse models of acute and chronic inflammatory pain.
    Rivas-Ramirez P; Gadotti VM; Zamponi GW; Weiss N
    Pflugers Arch; 2017 Oct; 469(10):1325-1334. PubMed ID: 28664409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium and sodium channel antagonists for the treatment of pain.
    Wallace MS
    Clin J Pain; 2000 Jun; 16(2 Suppl):S80-5. PubMed ID: 10870745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual Voltage-Gated Sodium Currents as Targets for Pain.
    Barbosa C; Cummins TR
    Curr Top Membr; 2016; 78():599-638. PubMed ID: 27586296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel substituted aminoquinoline selectively targets voltage-sensitive sodium channel isoforms and NMDA receptor subtypes and alleviates chronic inflammatory and neuropathic pain.
    Tabakoff B; Ren W; Vanderlinden L; Snell LD; Matheson CJ; Wang ZJ; Levinson R; Smothers CT; Woodward JJ; Honse Y; Lovinger D; Rush AM; Sather WA; Gustafson DL; Hoffman PL
    Eur J Pharmacol; 2016 Aug; 784():1-14. PubMed ID: 27158117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ion Channel Pharmacology for Pain Modulation.
    De Logu F; Geppetti P
    Handb Exp Pharmacol; 2019; 260():161-186. PubMed ID: 31820179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides.
    Feldman P; Khanna R
    Neurosci Lett; 2013 Dec; 557 Pt A(0 0):27-36. PubMed ID: 23831344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of sodium channels in nociception: implications for mechanisms of neuropathic pain.
    Liu M; Wood JN
    Pain Med; 2011 Jul; 12 Suppl 3():S93-9. PubMed ID: 21752183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel slow-inactivation-specific ion channel modulator attenuates neuropathic pain.
    Hildebrand ME; Smith PL; Bladen C; Eduljee C; Xie JY; Chen L; Fee-Maki M; Doering CJ; Mezeyova J; Zhu Y; Belardetti F; Pajouhesh H; Parker D; Arneric SP; Parmar M; Porreca F; Tringham E; Zamponi GW; Snutch TP
    Pain; 2011 Apr; 152(4):833-843. PubMed ID: 21349638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoform selective voltage-gated sodium channel modulators and the therapy of pain.
    Jukič M; Kikelj D; Anderluh M
    Curr Med Chem; 2014; 21(2):164-86. PubMed ID: 24059240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of voltage-gated sodium channels by ubiquitin ligase NEDD4-2 in neuropathic pain.
    Laedermann CJ; Cachemaille M; Kirschmann G; Pertin M; Gosselin RD; Chang I; Albesa M; Towne C; Schneider BL; Kellenberger S; Abriel H; Decosterd I
    J Clin Invest; 2013 Jul; 123(7):3002-13. PubMed ID: 23778145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Discovery of voltage-gated sodium-channel blockers for the treatment of neuropathic pain].
    Watanabe S
    Nihon Yakurigaku Zasshi; 2012 Nov; 140(5):201-5. PubMed ID: 23138316
    [No Abstract]   [Full Text] [Related]  

  • 20. HYP-17, a novel voltage-gated sodium channel blocker, relieves inflammatory and neuropathic pain in rats.
    Lee JY; Kam YL; Oh J; Kim DH; Choi JS; Choi HY; Han S; Youn I; Choo HP; Yune TY
    Pharmacol Biochem Behav; 2017 Feb; 153():116-129. PubMed ID: 28024908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.